Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

WIL Research Acquires Ricerca Facility in Lyon, France

Published: Friday, June 21, 2013
Last Updated: Friday, June 21, 2013
Bookmark and Share
The addition of the 18,000-square meter facility fortifies WIL Research’s service offerings in Europe.

“As we listened to our clients and analyzed emerging trends in the pharmaceutical marketplace, it became clear that expansion of our biologic capabilities in Europe was the right move for us,” said David Spaight, WIL Research’s Chairman and Chief Executive Officer. “The Lyon operation leverages our existing capabilities in the United States and the Netherlands and creates a powerful new platform to deliver exceptional value to our clients. This definitive acquisition will double our capacity in Europe, strengthen our offerings to clients and enable WIL Research to accelerate the healthy growth rate we have achieved over the past three years in a challenging market environment.”

Dr. Michael Placke, President, Ricerca Biosciences LLC, explained, “This divestiture will fund significant capital investment into our Concord, Ohio business allowing us to expand and re-invigorate our integrated drug development services in chemical development, drug substance production, and drug safety and metabolism”.

Renamed WIL Research Europe - Lyon, the lab will retain its approximately 280 employees. Long-time Managing Director of the facility, Stéphane Bulle, will continue to lead the site and keep his current senior leadership team intact.

With the expansion, WIL Research strengthens its global position as a highly credible player serving the pharmaceutical and chemical industries and its commitment to client needs for nimbleness and customized services.

“While this acquisition expands our integrated safety assessment and associated services for pharmaceutical companies, it also enables us to enhance our focus on the chemical and agrochemical industries via our expert scientific staff in Den Bosch, The Netherlands,” added Spaight.

Over the past 45 years, the Lyon facility has developed a strong scientific reputation with European pharmaceutical clients in safety pharmacology and specialized services including continuous infusion and developmental and reproductive toxicology.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

WIL Research Partners with Three S Japan
Partnership to expand full portfolio of global safety assessment services to the Japanese market.
Friday, May 24, 2013
Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Influential Cancer Researcher Receives Agilent Thought Leader Award
Biologist Scott Lowe receives award in recognition for his contributions to cancer biology.
Gene-Editing Cures Genetic Blood Disorder in Mice
New technology may offer minimally invasive treatment for genetic disorders of the blood.
Immunotherapy Technique Holds Promise for Curing Food Allergies
Scientists develop immunotherapy technique that almost eliminating allergic response and anaphylactic response in food-allergic mice.
Antibodies from Ebola Survivors Neutralize Virus, Protect Lab Mice
Scientists discover antiboides generated from the blood of Ebola survivors can strongly combat the virus in the lab.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Observing Direct Inheritance of Gene-Silencing RNA
Research has allowed for the observation of double-stranded RNA molecule being passed from parent to offspring in roundworms.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
Nanoparticles Offer Promising Platform for Flavivirus Treatment
New nanoparticle effectively vaccinated mice against one dengue strain and could be created to target all four.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos